1.33 Guarantee-Time Bias & Trials, Philanthropy, and Cancer Research with Dr. Tom Beer
In this episode we discuss guarantee-time bias in…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
January 5, 20191h 32mExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode we discuss guarantee-time bias in the context of the recent JAMA Oncology paper titled "Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer". We also have an interview with Dr. Tom Beer, the Deputy Director of the OHSU Knight Cancer Institute, on clinical trials, leadership, philanthropy, and future directions in cancer research.
Profiling preexisting antibodies: doi.org/10.1001/jamaoncol.2018.5860
Back us on Patreon! www.patreon.com/plenarysession
Topics
medicineoncologyhealthpolicy